Abdominal Aortic Aneurysm Treatment Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is the Abdominal Aortic Aneurysm Treatment Market in 2026?

USD 2.4 billion in 2026, reaching USD 4.1 billion by 2036 at a 5.3% CAGR

The abdominal aortic aneurysm treatment market is estimated at USD 2.4 billion in 2026 and is forecast to reach USD 4.1 billion by 2036 at a 5.3% CAGR. Demand is shaped by aneurysm repair, where surgical and endovascular procedures treat abdominal aortic aneurysms. Surgery accounts for 62.0% of Treatment demand in 2026, while Hospitals hold 68.0% of end use.

The market was valued at USD 2.3 billion in 2025. Growth reflects rising aneurysm diagnosis and the shift toward endovascular repair. Demand is shaped by hospitals performing open surgery and endovascular aneurysm repair for elderly and high-risk patients diagnosed through ultrasound and imaging.

Abdominal aortic aneurysm treatment spans surgical and endovascular repair for aneurysm patients. Buyers judge devices through procedure outcomes and durability. Sourcing centers on hospital vascular surgery budgets.

Summary of the Abdominal Aortic Aneurysm Treatment Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Demand comes from surgical and endovascular aneurysm repair in elderly patients, lifted by ultrasound screening. Hospitals perform surgical and endovascular aneurysm repair for elderly patients requiring aneurysm treatment. Rising aneurysm diagnosis through ultrasound screening drives demand for treatment. Endovascular repair adoption drives demand for stent grafts and minimally invasive procedures.
Product and Segment View	Surgical repair and hospital settings lead the mix, with ultrasound the primary screening method. Surgery accounts for 62.0% of Treatment demand, anchored by open and endovascular aneurysm repair. Hospitals lead End User Type at 68.0% share as aneurysm surgery concentrates in hospitals. Ultrasound Imaging leads Diagnosis Type as the primary aneurysm screening method.
Geography and Competitive Outlook	China leads growth on diagnosis and hospital capacity, while majors compete on stent-graft durability and deployment. China is forecast to record 7.1% CAGR by 2036 due to aneurysm diagnosis and hospital capacity. India and the USA follow at 6.6% and 5.5% CAGR as screening and endovascular repair expand. Medtronic and Johnson & Johnson compete with Cook Medical through stent graft technology. Device durability and deployment separate suppliers.
Analyst Opinion	Durable endovascular stent grafts with reliable deployment will hold the strongest position as aneurysm diagnosis drives treatment demand. Suppliers that combine durable endovascular stent grafts with reliable deployment will hold the strongest position as rising aneurysm diagnosis drives abdominal aortic aneurysm treatment demand. Adoption is increasing due to endovascular aneurysm repair extending minimally invasive treatment. - Anurag Sharma, Principal Consultant at Future Market Insights

Why is the Abdominal Aortic Aneurysm Treatment Market growing?

Rising Surgery and hospital demand in abdominal aortic aneurysm repair

• Sustained demand for aneurysm surgery is shaped by hospitals treating elderly aneurysm patients.
• China is leading the way with growth of 7.1%, driven by aneurysm diagnosis, hospital capacity, and endovascular repair.
• The end-user segment is led by Hospitals at 68.0% share, supported by aneurysm surgery concentration.

Demand is rising because abdominal aortic aneurysms require surgical or endovascular repair to prevent rupture. Adoption is increasing due to endovascular aneurysm repair, which reduces procedure invasiveness, with hospitals performing open and endovascular repair for elderly and high-risk patients diagnosed through ultrasound imaging.

How is the Abdominal Aortic Aneurysm Treatment Market segmented?

By Treatment, End User Type, Diagnosis Type, Risk Category and Patient Type

• Surgery is projected to lead Treatment with 62.0% share in 2026 due to open and endovascular repair.
• Hospitals are expected to lead End User Type with 68.0% share in 2026 as aneurysm surgery concentrates there.
• Ultrasound Imaging is forecast to lead diagnosis type as the primary aneurysm screening method.

Why does surgery lead the Abdominal Aortic Aneurysm Treatment Market?

• Surgery is expected to hold 62.0% share in 2026 because open and endovascular repair are definitive aneurysm treatment.
• Its role in rupture prevention anchors treatment demand.

Hospitals hold 68.0% share, led by aneurysm surgery

• Hospitals form the leading end user at 68.0% share, anchored by aneurysm surgery and endovascular repair.
• Clinics follow as diagnosis and follow-up care extend.

Which Diagnosis Type leads the market?

• Ultrasound imaging leads diagnosis type as the primary aneurysm screening method.
• X-ray and CT imaging follow as surgical planning imaging extends.

Which risk category leads procurement?

• Moderate risk leads as it represents the largest treated aneurysm group.
• Low, high, and critical risk follow across the aneurysm severity spectrum.

Which patient type leads the market?

• Elderly patients lead patient Type at 46.0% share as aneurysm prevalence concentrates in older populations.
• Adult and genetic-risk patients follow as screening extends.

What drives and restrains the Abdominal Aortic Aneurysm Treatment Market?

Driven by aneurysm diagnosis and endovascular repair; restrained by procedure cost and surgical risk

Rising aneurysm diagnosis and endovascular repair support growth while procedure cost and surgical risk in elderly patients constrain treatment.

• Driver: Hospitals performing surgical and endovascular aneurysm repair for elderly patients generate demand as rising aneurysm diagnosis through screening drives treatment.
• Restraint: Treatment is constrained by aneurysm repair procedure cost and surgical risk in elderly and high-risk patients that limit intervention in some cases.
• Opportunity: Endovascular repair and improved stent graft durability can widen treatment by extending minimally invasive repair to higher-risk patients.

Aneurysm diagnosis is lifting treatment demand as hospitals repair abdominal aortic aneurysms. Surgery anchors demand while endovascular repair reduces invasiveness.

The market is led by structural demand from aneurysm repair. Surgery remains the leading treatment, while medication serves risk management. Constraints include procedure cost, surgical risk, and stent graft durability.

Which factors support expansion in the Abdominal Aortic Aneurysm Treatment Market?

Aneurysm repair procedures and diagnosis support market value across hospital and vascular channels

• Market value is supported by aneurysm repair procedures before diagnostic imaging adds demand.
• Supplier pricing reflects stent graft durability and deployment before surgical outcomes affect adoption.
• Vascular surgeons compare device durability and deployment before standardizing on a stent graft.

Which countries are growing fastest in the Abdominal Aortic Aneurysm Treatment Market?

Country	CAGR
China	7.1%
India	6.6%
USA	5.5%
European Union	5.3%
South Korea	5.2%
Japan	5.1%
UK	5.0%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in the Abdominal Aortic Aneurysm Treatment Market?

The global abdominal aortic aneurysm treatment market is projected to expand at 5.3% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

• China is forecast to record 7.1% CAGR by 2036 as aneurysm diagnosis and hospital capacity accelerate.
• India is expected to expand at 6.6% CAGR through 2036 as screening and endovascular repair grow.
• The USA is estimated to grow at 5.5% CAGR by 2036 as endovascular repair adoption expands.
• The European Union is projected to rise at 5.3% CAGR through 2036 as aneurysm treatment widens.
• South Korea, Japan, and the UK round out the study at 5.0% to 5.2% CAGR through 2036.

Who are the leading companies in the Abdominal Aortic Aneurysm Treatment Market?

Medtronic, Johnson & Johnson, Cook Medical, Endologix, and Boston Scientific

Medtronic and Johnson & Johnson compete through stent graft and endovascular device portfolios. Device durability remains a further point of differentiation. Cook Medical and Endologix compete on aneurysm repair devices, while Boston Scientific holds positions in vascular intervention. These overlap with broader vascular surgery and endovascular buying paths.

Buyers compare suppliers on device durability, deployment, and clinical evidence. Vascular centers standardize on stent grafts with proven durability. Surgeons favor suppliers offering reliable deployment systems with strong endovascular repair evidence.

Who are the key players in the Abdominal Aortic Aneurysm Treatment Market?

Key global companies leading the Abdominal Aortic Aneurysm Treatment Market include:

• Medtronic, Johnson & Johnson, and Cook Medical maintain leading positions through stent graft portfolios, device durability, and vascular-center relationships across global markets.
• Endovascular device players such as Endologix, Boston Scientific, and Terumo compete through aneurysm repair devices.
• Specialist and emerging providers such as Abbott Laboratories, Bard Peripheral Vascular, and Medionics target vascular devices to establish positions and scale.

How do top Abdominal Aortic Aneurysm Treatment Market companies compare?

Medtronic and J&J lead on scale; Cook Medical also has a global footprint, while Endologix and Boston Scientific are more device-concentrated.

Company	Product Breadth	Device Durability	Distribution Scale	Geographic Footprint
Medtronic	High	High	Strong	Global
Johnson & Johnson	High	High	Strong	Global
Cook Medical	High	High	Strong	Global
Endologix	Moderate	High	Moderate	Americas-led
Boston Scientific	Moderate	High	Strong	Global

Source: Future Market Insights competitive analysis, 2026.

Key Developments in the Abdominal Aortic Aneurysm Treatment Market

• In October 2025, Medtronic received FDA labeling approval for the Endurant stent graft system adding ruptured abdominal aortic aneurysm clinical evidence and removing the rAAA treatment warning, making it the first and only EVAR system with this labeling change following FDA review of international real-world data. On-label emergency use reframes EVAR from off-label practice to sanctioned protocol in ruptured cases. Labeling evidence supports vascular surgery departments assessing whether endovascular repair can become first-line in emergency rupture before revising trauma pathways. 

• In July 2026, W. L. Gore & Associates received FDA approval for updated labeling on the Excluder AAA Endoprosthesis and Excluder Conformable AAA Endoprosthesis, adding real-world clinical evidence supporting EVAR use in appropriately selected ruptured AAA patients and removing the prior warning. A second manufacturer securing rAAA labeling establishes the change as a category-wide regulatory shift. Competitive parity evidence supports procurement teams comparing device options without labeling restrictions before consolidating stent graft contracts. 

• In April 2026, Hjarta Care received FDA de novo authorisation for EVAR XplantR, a purpose-built single-use device designed for explantation of aortic endografts following endovascular aneurysm repair. Dedicated explant tooling addresses the growing reintervention burden from ageing EVAR implant populations. Device-availability evidence supports vascular centres planning for late EVAR failure management before reintervention volumes increase. 

 

Key Players in the Abdominal Aortic Aneurysm Treatment Market

Global Vascular Device Leaders

• Medtronic plc
• Johnson & Johnson
• Cook Medical

Endovascular Repair Specialists

• Endologix, Inc.
• Boston Scientific
• Terumo Corporation

Emerging and Regional Players

• Abbott Laboratories
• Bard Peripheral Vascular, Inc.
• Medionics Ltd.

Abdominal Aortic Aneurysm Treatment Market - Scope & Definition

Attribute	Detail
Market Definition	Abdominal aortic aneurysm treatment including surgical and endovascular repair and medication used to treat aneurysms across risk categories and patient types
Functions Covered	Open surgical repair, endovascular aneurysm repair, aneurysm diagnosis, and risk management across treatment
Applications Covered	Surgical repair, endovascular repair, and medication-based aneurysm management
End-Use Industries	Hospitals and clinics
Inclusions	Surgical repair, endovascular stent grafts, antihypertensive and antilipidemic medication, and diagnostic imaging
Exclusions	Thoracic aortic aneurysm treatment outside abdominal, and non-aneurysm vascular procedures

Abdominal Aortic Aneurysm Treatment Market - Research Methodology

Method	Description
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing & Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

What does the Abdominal Aortic Aneurysm Treatment Market report cover?

2021 to 2025 history and 2026 to 2036 forecasts across all segments and 30+ countries

Parameter	Details
Forecast period	2026 to 2036
Historical period	2021 to 2025
Quantitative unit	Value in USD billion
By Treatment	Surgery, Open Surgery, Medication, Antihypertensive, Antilipidemics
By End User Yype	Hospitals, Clinics
By Diagnosis Type	Ultrasound Imaging, X-Ray Imaging
By Risk Category	Moderate Risk, Low Risk, High Risk, Critical Risk
By Patient Type	Elderly Patients, Adult Patients, Genetic Risk Patients, High Risk Lifestyle Patients
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, China, India, European Union, South Korea, Japan, UK, and other major markets
Key companies profiled	Medtronic, Johnson & Johnson, Cook Medical, Endologix, Boston Scientific, Terumo, Abbott Laboratories, Bard Peripheral Vascular
Approach	Bottom-up procedure-based approach using aneurysm repair volume, treatment mix, patient type, and supplier disclosures

Market Segmentation Analysis

Abdominal Aortic Aneurysm Treatment Market Segmented by Treatment:

• Surgery
• Open Surgery
  • Traditional Surgical Repair
    • Aortic Graft Replacement
    • High Risk Invasive Procedure
  • Endovascular Aneurysm Repair (EVAR)
  • Minimally Invasive Procedure
    • Stent Graft Placement
    • Faster Recovery Time
• Medication
• Antihypertensive
  • Beta Blockers
    • Blood Pressure Control
    • Aneurysm Growth Reduction
  • ACE Inhibitors
    • Vascular Pressure Management
    • Cardiovascular Protection
• Antilipidemics
  • Statins
    • Cholesterol Reduction Therapy
    • Atherosclerosis Management
  • Fibrates
    • Triglyceride Control
    • Lipid Regulation Therapy

Abdominal Aortic Aneurysm Treatment Market Segmented by End User Type:

• Hospitals
  • Tertiary Care Hospitals
    • Advanced Vascular Surgery Units
    • Emergency Surgical Care
  • Cardiac Specialty Hospitals
    • Endovascular Treatment Centers
    • High Risk Patient Management
• Clinics
  • Vascular Clinics
    • Outpatient Monitoring
    • Early Diagnosis And Screening
  • Cardiology Clinics
    • Preventive Care Services
    • Follow Up Treatment Management

Abdominal Aortic Aneurysm Treatment Market Segmented by Diagnosis Type:

• Ultrasound Imaging
  • Abdominal Ultrasound
    • Initial Screening Method
    • Non Invasive Detection
  • CT Angiography (CTA)
  • Contrast Enhanced Imaging
    • High Precision Aneurysm Measurement
    • Pre Surgical Planning
  • MRI Angiography
    • Detailed Vascular Imaging
    • Soft Tissue Evaluation
• X-Ray Imaging
  • Conventional Radiography
    • Supportive Diagnostic Tool
    • Structural Assessment

Abdominal Aortic Aneurysm Treatment Market Segmented by Risk Category:

• Moderate Risk
  • Medium Sized Aneurysms
    • Scheduled Surgical Evaluation
    • Medical Management Required
• Low Risk
  • Small Aneurysms
    • Regular Monitoring Cases
    • Non Immediate Intervention
• High Risk
  • Large Aneurysms
    • Immediate Surgical Need
    • High Rupture Probability
• Critical Risk
  • Ruptured Aneurysms
    • Emergency Surgery Cases
    • Life Threatening Condition

Abdominal Aortic Aneurysm Treatment Market Segmented by Patient Type:

• Elderly Patients
  • Age Above 65 Years
    • High Prevalence Group
    • Comorbidity Management
• Adult Patients
  • Age 40 To 65 Years
    • Lifestyle Related Risk
    • Preventive Screening Group
• Genetic Risk Patients
  • Family History Cases
    • Hereditary Aneurysm Risk
    • Early Detection Monitoring
• High Risk Lifestyle Patients
  • Smokers And Hypertensive Individuals
    • Accelerated Disease Progression
    • Frequent Monitoring Required

Abdominal Aortic Aneurysm Treatment Market by Region:

• North America
  • USA
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• World Health Organization. (2025, October). Global report on cardiovascular disease and aneurysm treatment.
• Organisation for Economic Co-operation and Development. (2025, November). Health at a Glance: vascular surgery access.
• USA Food and Drug Administration. (2026, February 9). Device clearances for endovascular stent grafts.
• European Commission. (2025, December 6). Medical Device Regulation guidance for vascular devices.
• Society for Vascular Surgery. (2025, September). Abdominal aortic aneurysm treatment guidelines.
• Medtronic plc. (2026, February 18). 2025 annual report and aortic portfolio overview.
• Boston Scientific. (2026, February 5). 2025 results and peripheral interventions update.

This bibliography is provided for reader reference and is not exhaustive.

This Report Answers

• Market size estimates for 2026 and forecasts through 2036 for the Abdominal Aortic Aneurysm Treatment Market.
• Analysis of treatment demand across surgical and endovascular aneurysm repair.
• Country-level growth analysis covering China and India with USA, European Union, South Korea and additional country outlooks.
• Evaluation of company positioning across Medtronic and Johnson & Johnson with Cook Medical, Endologix and Boston Scientific.
• Assessment of drivers and restraints with treatment patterns across hospital and vascular channels.